EMERALD ADVISERS, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2016$69,000
-97.7%
12,307
-97.8%
0.00%
-97.9%
Q2 2016$3,028,000
-26.2%
551,521
-0.2%
0.15%
-27.0%
Q1 2016$4,101,000
-14.7%
552,751
-4.5%
0.20%
-11.9%
Q4 2015$4,810,000
+8.1%
578,805
+17.2%
0.23%
-2.2%
Q3 2015$4,451,000
-26.2%
493,966
-1.8%
0.23%
-19.4%
Q2 2015$6,033,000
+79.3%
502,770
+37.8%
0.29%
+70.4%
Q1 2015$3,364,000
+151.8%
364,808
+38.4%
0.17%
+138.0%
Q4 2014$1,336,000
+18985.7%
263,508
+14872.0%
0.07%
Q2 2014$7,0001,7600.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2016
NameSharesValueWeighting ↓
Belmont Global Advisors, Inc. 2,564,925$11,132,0008.99%
Essex Woodlands Management, Inc. 2,764,908$11,330,0005.70%
Third Security, LLC 17,815,708$77,320,0003.68%
MSD Partners, L.P. 2,750,000$11,935,0000.49%
SFMG, LLC 99,850$433,0000.15%
GM Advisory Group, LLC 12,500$54,0000.06%
Geduld E E 25,000$109,0000.05%
WESTPORT RESOURCES MANAGEMENT INC 30,500$132,0000.04%
Janney Montgomery Scott LLC 335,571$1,456,378,0000.04%
WFG Advisors, LP 48,040$208,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders